Back to Results
First PageMeta Content
Nephrology / Medical emergencies / Kidney diseases / Acute kidney injury / Sepsis / Multiple organ dysfunction syndrome / Acute respiratory distress syndrome / Renal failure / Dialysis / Medicine / Organ failure / Intensive care medicine


http://www.businesswire.com/news/homeen/CytoPherx-Raises-34-Million-Move-U.S.-Clinical
Add to Reading List

Document Date: 2012-01-05 13:37:39

Open Document

File Size: 26,85 KB

Share Result on Facebook

City

ANN ARBOR / /

Company

CytoPherx Inc. / Emergent Medical Partners / Kaiser Permanente Ventures / Union Carbide / ONSET Ventures / Aphelion Capital / Roeder-Johnson Corporation / Early Stage Partners / Apjohn Ventures / /

Country

United States / /

Currency

USD / /

Event

Funding / /

Facility

Mike Bunker of Early Stage Partners / /

MedicalCondition

long term illness / acute kidney injury / clinical stage medical device company addressing inflammation-based diseases / severe sepsis / kidney injury / Systemic inflammation / inflammatory disease / extreme systemic inflammation / inflammation / acute systemic inflammation / acute renal failure / /

MedicalTreatment

dialysis / /

Organization

Capital Midwest Fund / FDA / Early Stage Partners / ONSET Ventures and Capital Midwest Fund / /

Person

H. David Humes / Jim Danehy / Leslie Bottorff / Paul Michelson / /

/

Position

President and CEO / /

Product

Selective Cytopheretic Device / /

ProvinceOrState

ARDS / Michigan / /

Technology

dialysis / /

URL

http /

SocialTag